Table of Contents

• 1.1 List of Tables 3
• 1.2 List of Figures 3

2 Introduction 4

• 2.1 Peripheral Nerve Stimulators (PNS) Overview 4

3 Products under Development 5

• 3.1 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
• 3.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
• 3.3 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
• 3.4 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
• 3.5 Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9

4 Peripheral Nerve Stimulators (PNS) - Pipeline Products under Development by Companies 10

• 4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development 10
• 4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 11

5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview 12

• 5.1 Actuated Medical Inc Company Overview 12
  • 5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
• 5.2 Cardionomic Inc (Inactive) Company Overview 13
  • 5.2.1 Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
• 5.3 Checkpoint Surgical Inc Company Overview 14
  • 5.3.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
• 5.4 EMKinetics, Inc. Company Overview 15
  • 5.4.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
• 5.5 Epineuron Technologies Inc Company Overview 18
  • 5.5.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.6 Gondola Medical Technologies SA Company Overview 19
  • 5.6.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
• 5.7 Remedee Labs SAS Company Overview 22
  • 5.7.1 Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.8 Washington University School of Medicine Company Overview 25
  • 5.8.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25

6 Peripheral Nerve Stimulators (PNS)- Recent Developments 26

• 6.1 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled 26
• 6.2 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital 26
• 6.3 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET) 26
• 6.4 Aug 21, 2019: SPR Therapeutics SPRINT Peripheral Nerve Stimulation System significantly reduces opioid use in patients with low back pain, interim data show 27
• 6.5 Apr 08, 2019: Study of SPR Therapeutics Peripheral Nerve Stimulation System demonstrates significant and sustained relief of post-amputation pain 28
• 6.6 Jan 17, 2019: Cala Health enrolls first patients in landmark PROSPECT study for essential tremor 29
• 6.7 Jan 15, 2019: SPR Therapeutics names Dr. Peter Staats as Chief Medical Advisor 30

7 Appendix 31

• 7.1 Methodology 31
• 7.2 About GlobalData 34
• 7.3 Contact Us 34

Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Nerve Stimulators (PNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Nerve Stimulators (PNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date